Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : PYNG Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Edward W. Richmond who wrote (4604)	9/27/1999 5:00:00 PM
From: m. jacobs	Read Replies (2) \| Respond to of 8117

PYNG TECHNOLOGIES CORP. PYT.V NEWS RELEASE September 27, 1999 OTC.BB-PYNGF PYNG MEDICAL LAUNCHES INTERNATIONAL MARKETING FOR F.A.S.T.1 SYSTEM FOR ADULT INTRAOSSEOUS INFUSION Pyng Technologies announced today that subsidiary Pyng Medical Corp has retained the exclusive services of Mr. Paul Mathias, as International Marketing Consultant. Mr. Mathias task will be to define and implement a comprehensive marketing plan in the critical product launch stages of commercializing the F.A.S.T.1 System for Adult Intraosseous Infusion. As an exclusive International Marketing Consultant to Pyng, Paul Mathias brings over 17 years of marketing and sales management experience in the medical device industry with such companies as Johnson and Johnson, Baxter International, and Xillix. Mr. Mathias will utilize all of his considerable skills to grow international product revenues for the F.A.S.T.1 System through partner organizations in the United States, Europe, Japan and Asia. As the exclusive International Marketing Consultant, Mr. Mathias will be responsible for working with management to develop and implement global marketing, sales and distribution plans for the imminent release of the F.A.S.T.1 System for Adult Intraosseous Infusion. This coincides with Pyng Medical Corp. recent news release that it has signed a production contract for the F.A.S.T.1 System with Comptec International. Commenting on the additional marketing support, Michael W. Jacobs, President of Pyng noted, " As we transition from the development stages to the commercialization stages with the F.A.S.T. 1 System we are pleased to have access to Paul's international knowledge and experience in marketing medical devices". Pyng Medical Corp. and Mr. Paul Mathias mutually agree that there will be an option to convert this exclusive consulting roll to the position of Vice-President of International Marketing, with involvement on the executive board of Pyng Medical Corp., if satisfactory goals are met. Pyng Technologies is the world leader in the development of Sternal Access Adult Intraosseous Infusion Systems. The F.A.S.T.1 System is a patented, life saving technology for the infusion of volume replacement fluids and medications with applications in emergency response, hospital and military markets. The FDA in the USA and the HPB in Canada have cleared the F.A.S.T. 1 System to market. For further information please contact Michael W. Jacobs, President at 1-800-349-7964 or visit our web site at www.pyng.com The VSE has neither reviewed or approved of the contents of this news release